Delving into the Latest Updates on Amco Inc. with Synapse

Overview

Tags

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

SCNA x μ opioid receptor	1

Abstract: Fresenius AS.TEC204 is a third‐generation blood cell separatorthat incorporates the continuous centrifugal separation method andautomatic control of the cell separation process. Continuous centrifugationseparates cell components according to their specific gravity, anddifferent cell components are either harvested or eliminated asneeded. The interface between the red blood cell and plasma is opticallydetected, and the Interface Control (IFC) cooperates with differentpumps, monitors and detectors to harvest required components automatically. Thesystem is composed of three major sections; the Front Panel Unit;the Pump Unit, and the Centrifuge Unit. This unit can be used fora wide variety of clinical applications including collection ofplatelets, peripheral blood stem cells, bone marrow stem cells,granulocytes, mononuclear cells, and exchange of plasma or red cells,and for plasma treatment.

100 Deals associated with Amco Inc.

Login to view more data

100 Translational Medicine associated with Amco Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data